Diclofenac ophthalmic - InSite Vision

Drug Profile

Diclofenac ophthalmic - InSite Vision

Alternative Names: ISV-205

Latest Information Update: 23 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator InSite Vision
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; TIGR protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Glaucoma; Ocular inflammation; Ocular pain

Most Recent Events

  • 31 Dec 2006 This programme is still in active development for ocular pain and inflammation
  • 12 Dec 2004 Suspended - Phase-II for Glaucoma in USA (Ophthalmic)
  • 31 Dec 2002 Preclinical trials in Ocular inflammation in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top